Anixa (ANIX) Director Arnold M. Baskies Exercises Options

What Happened
Arnold M. Baskies, a director of Anixa Biosciences, exercised 6,000 stock options on July 27, 2026. The exercise was recorded as 6,000 shares acquired at an exercise price of $3.13 per share (total $18,780). To cover the exercise price and related tax liabilities, 5,428 of those shares were withheld (disposed) at a reported value of $3.46 per share (total ~$18,781), leaving a net delivery to Baskies of 572 shares. The filing shows the option conversion and the withholding as related transactions.

Key Details

• Transaction date: July 27, 2026 (reported on Form 4 filed July 29, 2026 — appears timely).
• Option exercise: 6,000 shares exercised at $3.13/share (total $18,780).
• Withholding (tax/exercise payment): 5,428 shares withheld at $3.46/share (total ~$18,781) to cover exercise price/taxes (transaction code F).
• Net shares to insider: 572 shares (6,000 exercised − 5,428 withheld).
• Footnotes: F1 — exercise done because options expire Aug 23, 2026; F2 — options are a Right‑To‑Buy from an Aug 23, 2013 grant.
• Transaction codes: M = option exercise/conversion; F = shares withheld to satisfy exercise price/tax liability.
• Shares owned after transaction: not provided in the supplied data.

Context
This was a routine option exercise with a cashless element (shares withheld to cover costs), not an open‑market buy or sale. Such exercises are common when options are near expiration and do not necessarily signal the insider’s market view. The dollar amounts are modest (~$18.8K), so this is a small insider transaction relative to typical large insider trades.